Advancing Research in Augmentative and Alternative Communication (AAC) (R21 Clinical Trial Optional)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website    Save

Next deadline: Nov 16, 2021

Later deadlines: Jan 7, 2022

Grant amount: Up to US $275,000

Fields of work: Communication Disorders

Applicant type: Organizations

Funding uses: Biomedical, Behavioral

Location of project: Anywhere in the world

Location of residency: Anywhere in the world


This funding opportunity announcement (FOA) seeks Exploratory/Developmental Research Grants (R21) applications on Augmentative and Alternative Communication (AAC) to advance our scientific knowledge in the evaluation and treatment of individuals with severe speech and physical impairments, (SSPI). AAC is a set of tools and strategies that an individual uses to solve everyday communicative challenges. Augmentative and alternative communication (AAC) helps millions worldwide who cannot rely on their natural speech to communicate. This FOA is for R21s only and encourages a range of research inclusive of basic, clinical, and translational.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

This page was last reviewed November 02, 2018 and last updated November 02, 2018